Mundipharma Pharmaceuticals B.V. clinical trials
A country office of Mundipharma
The registry lists 4 studies whose lead sponsor is Mundipharma Pharmaceuticals B.V.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 9, 2019.
Registry sponsor names on this page
- Mundipharma Pharmaceuticals B.V.3 studies
- Mundipharma Pharmaceuticals srl1 study
Something wrong with this grouping? Tell us on the Mundipharma page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Mundipharma studies →
- Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA)CompletedNCT03585374Phase 3
Sponsor listed in the registry: Mundipharma Pharmaceuticals srl
- Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.WithdrawnNCT02811315
Sponsor listed in the registry: Mundipharma Pharmaceuticals B.V.
- Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant PainCompletedNCT01167127Phase 3
Sponsor listed in the registry: Mundipharma Pharmaceuticals B.V.
- Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant PainCompletedNCT01167699Phase 3
Sponsor listed in the registry: Mundipharma Pharmaceuticals B.V.